Trace Doctor

The description states that Trace Doctor is "an AI debugging copilot for agent developers" that processes failed agent traces and outputs structured information including:

• Failure category
• Root cause
• Evidence (trace-backed)
• Recommended fix
• Regression test

It accepts a simplified JSON trace format with user request, available tools, steps, and final answer. The output is also in structured JSON.

The author describes it as built as a web app with a diagnosis pipeline that includes:

• Sample failed traces
• JSON trace paste/upload capability
• Local deterministic diagnosis engine
• OpenAI-powered diagnosis route with structured output
• UI components for root cause cockpit, evidence panel, recommended fix diff, and regression test generator

Inference The product appears to be a proof-of-concept debugging tool that sits on top of existing tracing infrastructure rather than replacing it.

The description states that Trace Doctor focuses on the "missing layer: diagnosis" — specifically addressing the gap between tracing tools showing what happened and developers manually figuring out why.

It positions itself as:

• Not a full observability platform
• A focused MVP for agent debugging
• An AI debugging copilot
• A "failure-to-eval compiler"

The author notes that the inspiration came from common agent development problems where tracing shows failures but doesn't help identify root causes or suggest fixes.

Inference The positioning evolved from a general debugging tool to a specific workflow focused on actionable diagnosis and regression testing, with an emphasis on step-level precision and trace-backed evidence.

The description states that Trace Doctor is for "agent developers" — specifically those who build agents that make tool calls or interact with external systems.

It targets users who:

• Develop AI agents using frameworks
• Encounter failures in agent behavior (e.g., incorrect tool selection)
• Need to understand why an agent failed and how to fix it

The author mentions that the product is built for a "hackathon MVP" rather than a full platform, suggesting early-stage targeting.

Inference The ICP appears to be individual developers or small teams building LLM-powered agents who need debugging assistance during development.

Not evidenced. The description does not mention any pricing model, monetization strategy, or business model.

The project is built with:

• Frontend: React, Next.js, Tailwind CSS
• Backend: Python, TypeScript, Codex
• AI integration: OpenAI-powered diagnosis route
• Data format: JSON trace input/output
• Architecture: Web app with structured diagnosis pipeline

It includes features like:

• Local deterministic diagnosis engine
• Structured output for UI rendering
• Sample traces and upload capability
• Root cause cockpit, evidence panel, fix diff, regression test generator

Inference The technical approach is lightweight and focused on a specific workflow. It uses existing tools (like OpenAI) rather than building proprietary infrastructure.

Not evidenced. There is no mention of:

• Revenue
• Customers
• Usage metrics
• Product adoption
• Prior versions or iterations
• Market validation

The description explicitly states that this was a hackathon MVP and that the author built it as such, with no indication of prior traction.

Not evidenced. The description does not mention:

• Competitors
• Existing solutions in the market
• Differentiation from similar tools
• Market size or landscape

Inference Based on the description alone, there is no evidence of competitive positioning or awareness of existing debugging or observability tools for agents.

1. No commercial traction: The project is described as a hackathon MVP with no evidence of revenue, customers, or adoption.
2. Single-person team: Only one member listed (mirandawang1023), which may limit execution capacity.
3. Unproven market demand: No evidence that developers actually need this specific workflow or would pay for it.
4. Limited scope: The MVP is described as intentionally narrow, potentially limiting long-term viability.
5. Dependency on external AI services: Reliance on OpenAI for diagnosis may create scalability and cost concerns.
6. Lack of validation: No mention of user feedback, testing, or iteration beyond the hackathon.

1. What specific agent development workflows are you targeting, and how do you know developers need this?
2. Have you tested this with actual developers in real-world scenarios?
3. How do you plan to scale beyond a single-person MVP?
4. What is your path to monetization or commercial viability?
5. Are there any existing tools that already solve similar problems?
6. How do you intend to validate the accuracy and usefulness of your diagnosis outputs?